Dr. Leslie R. Boyd, MD

Dr. Boyd practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

Dr. Boyd's NPI, 1497967079, was assigned on May 4, 2007. Dr. Boyd graduated from Yale School of Medicine in 2000. Dr. Boyd holds New York license 228120.

Dr. Boyd's primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.

Dr. Boyd's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Boyd is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Boyd to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyd practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Boyd's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Boyd is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Boyd is licensed in New York.

Dmand AI lists hysterectomy, menopause and ovarian cyst among the conditions Dr. Boyd treats.

CMS data shows 413 Medicare services from Dr. Boyd across 7 procedure codes in 2024, for 165 Medicare patients. Medicare paid $42,237 for them.

CMS counts 165 Medicare patients who saw Dr. Boyd in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boyd's median patient age at 65, with 96% women.

In 2024, Dr. Boyd wrote 13 Medicare Part D claims.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Boyd for performance year 2024, reported as part of a group. Dr. Boyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boyd as offering telehealth. CMS counts 17 procedures of removal of the uterus by Dr. Boyd, more than 90% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Boyd, published from 2010 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Endometrial Neoplasms. Dr. Boyd has published most often in Gynecol Oncol. Dr. Boyd's most frequent co-authors are John Curtin, MD, Stephanie V. Blank, MD and Bhavana Pothuri, MD.

Dmand AI links Dr. Boyd to 5 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Uterine Cervical Neoplasms, Uterine Cervical Diseases and Squamous Intraepithelial Lesions.

CMS Open Payments shows 10 general payments to Dr. Boyd from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,539.

Dmand AI lists 1 award for Dr. Boyd, most recently CMS Stage 1 EHR in 2013.

Dr. Boyd graduated from Yale School of Medicine in 2000.

Dr. Boyd is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.